How COVID adapatations may affect PrEP provision…
Update on 2021 DHHS HIV treatment guidelines
More regulatory changes and important…
Updated 2021 CDC STI treatment guidelines on…
USPSTF/CDC updated 2020 recommendations for HCV…
Regulatory changes and important considerations…
Dr. Landovitz discusses HPTN 083, an efficacy…
Overview of Fostemsavir, a recently approved…
HIV PEP/PrEP case scenarios
2020 IAS-USA HIV prevention guidelines update
nPEP guidelines, access barriers, and potential…
2020 IAS-USA HIV treatment guidelines update
2020 CROI highlights on ART safety and side…
Update on 2019 DHHS guidelines for opportunistic…
Highlights of DHHS 2020 interim guidance on COVID…
How the vaginal microbiota impacts HIV…
Update on 2019 DHHS gudielines on 2-Drug and…
CDC STD interim guidance on managing STDs in…